Abstract
Selective response: The fully synthetic vaccine shown, which contains a glycopeptide antigen from the tumor-associated mucin MUC1 and an immunostimulating T-cell epitope from ovalbumin, induces a highly specific immune response in mice. The induced antibody reacts with the glycopeptides and analogues that carry additional tumor-associated TN antigen monosaccharides in their sequence.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
